Q32 Bio (QTTB) Change in Acquisitions & Divestments (2018 - 2024)
Q32 Bio's (QTTB) quarterly Change in Acquisitions & Divestments came in at $10.0 million in Q3 2024, up 0.98% quarter-over-quarter from $9.9 million in Q2 2024.
Q32 Bio (QTTB) Change in Acquisitions & Divestments (2018 - 2024) Analysis & Trends
Q32 Bio's Change in Acquisitions & Divestments history runs 6 years deep, the most recent figure standing at $10.0 million for Q3 2024.
- On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $10.0 million in Q3 2024; TTM through Jun 2025 was $10.0 million, a 0.0% change from a year earlier, with the FY2024 full-year figure at $20.0 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments rose to $10.0 million in Q3 2024 per QTTB's latest filing, from $9.9 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $117.0 million in Q1 2020 and bottomed at $97000.0 in Q1 2024.
- The 4-year median for Change in Acquisitions & Divestments is $39.0 million (2020), against an average of $39.8 million.
- Across the five-year window, Change in Acquisitions & Divestments advanced 2.12% in 2020 and slumped 59.09% in 2022, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $39.0 million in 2020, then climbed by 12.82% to $44.0 million in 2021, then slumped by 59.09% to $18.0 million in 2022, then plunged by 44.44% to $10.0 million in 2024.
- Per Business Quant, the three latest QTTB Change in Acquisitions & Divestments figures stand at $10.0 million (Q3 2024), $9.9 million (Q2 2024), and $97000.0 (Q1 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.57 Bn | 466.77 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.01 Bn | 114.76 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn |
| 10 | Q32 Bio | 213.69 Mn | 162.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 10.00 Mn |
| Sep 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | 9.90 Mn |
| Jun 30, 2024 | 9.90 Mn |
| Mar 31, 2024 | 97,000.00 |
| Mar 31, 2024 | 97,000.00 |
| Dec 31, 2022 | 18.00 Mn |
| Dec 31, 2022 | 18.00 Mn |
| Jun 30, 2022 | 47.46 Mn |
| Jun 30, 2022 | 47.46 Mn |
| Dec 31, 2021 | 44.00 Mn |
| Dec 31, 2021 | 44.00 Mn |
| Sep 30, 2020 | 39.00 Mn |
| Sep 30, 2020 | 39.00 Mn |
| Jun 30, 2020 | 72.59 Mn |
| Jun 30, 2020 | 72.59 Mn |
| Mar 31, 2020 | 117.03 Mn |
| Mar 31, 2020 | 117.03 Mn |
| Dec 31, 2019 | 12.70 Mn |
| Dec 31, 2019 | 12.70 Mn |